California prisons saw more than 20,000 COVID-19 Omicron cases over a five-month period. However, vaccination and boosting kept hospitalization and death rates low.

UCSF experts discuss the current state of Alzheimer’s treatments and future therapies that may slow progression of the disease.

Researchers have genetically engineered cells to distract antibodies from attacking friendly, but foreign, cells. This could prevent transplants from being rejected.

Researchers have discovered a cellular uptake pathway for larger molecules that delivers cell-permeable drugs efficiently.

Through decades of biobanking at UCSF, researchers were able to comprehensively map intra-cellular signaling in the cells of recurrent glioblastoma, identifying novel cell-extrinsic therapeutic targets.

While we sleep, our brains process our daily actions to create motor memory, which makes physical acts such as throwing a basketball subconscious.

Groundbreaking research by UCSF scientists has led to FDA approval of a new therapy that can delay the onset of type 1 diabetes by at least 2 years.